BLACKROCK SCIENCE & TECH TR (BST) Fundamental Analysis & Valuation

NYSE:BST • US09258G1040

39.13 USD
-0.67 (-1.68%)
Last: Mar 6, 2026, 08:04 PM
Overview Stock Chart Technical Analysis News

This BST fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

BST gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. While BST seems to be doing ok healthwise, there are quite some concerns on its profitability. BST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. BST Profitability Analysis

1.1 Basic Checks

  • In the past year BST was profitable.
  • In the past year BST had a positive cash flow from operations.
  • Of the past 5 years BST 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: BST reported negative operating cash flow in multiple years.
BST Yearly Net Income VS EBIT VS OCF VS FCFBST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA 11.54%
ROE 11.76%
ROIC N/A
ROA(3y)-8.09%
ROA(5y)4.63%
ROE(3y)-8.04%
ROE(5y)4.83%
ROIC(3y)N/A
ROIC(5y)N/A
BST Yearly ROA, ROE, ROICBST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

  • In the last couple of years the Profit Margin of BST has declined.
  • The Operating Margin and Gross Margin are not available for BST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3180.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y17.43%
PM growth 5Y-3.35%
GM growth 3YN/A
GM growth 5YN/A
BST Yearly Profit, Operating, Gross MarginsBST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K 20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BST Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BST has been increased compared to 1 year ago.
  • Compared to 5 years ago, BST has more shares outstanding
  • BST has a better debt/assets ratio than last year.
BST Yearly Shares OutstandingBST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BST Yearly Total Debt VS Total AssetsBST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 31.35 indicates that BST is not in any danger for bankruptcy at the moment.
  • BST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 31.35
ROIC/WACCN/A
WACCN/A
BST Yearly LT Debt VS Equity VS FCFBST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • BST has a Current Ratio of 1.06. This is a normal value and indicates that BST is financially healthy and should not expect problems in meeting its short term obligations.
  • BST has a Quick Ratio of 1.06. This is a normal value and indicates that BST is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
BST Yearly Current Assets VS Current LiabilitesBST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BST Growth Analysis

3.1 Past

  • BST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.20%.
  • Measured over the past years, BST shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.82% on average per year.
  • BST shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.96%.
  • BST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)-38.2%
EPS 3Y22.37%
EPS 5Y-3.82%
EPS Q2Q%-54.64%
Revenue 1Y (TTM)35.96%
Revenue growth 3Y7.3%
Revenue growth 5Y8.06%
Sales Q2Q%58.96%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BST Yearly Revenue VS EstimatesBST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

1

4. BST Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.26, the valuation of BST can be described as reasonable.
  • BST is valuated cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.26
Fwd PE N/A
BST Price Earnings VS Forward Price EarningsBST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 13.06
EV/EBITDA N/A
BST Per share dataBST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. BST Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 9.93%, BST is a good candidate for dividend investing.
  • BST's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 9.93%

5.2 History

  • The dividend of BST decreases each year by -1.74%.
  • BST has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of BST decreased in the last 3 years.
Dividend Growth(5Y)-1.74%
Div Incr Years0
Div Non Decr Years2
BST Yearly Dividends per shareBST Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • 62.65% of the earnings are spent on dividend by BST. This is not a sustainable payout ratio.
  • BST's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP62.65%
EPS Next 2YN/A
EPS Next 3YN/A
BST Yearly Income VS Free CF VS DividendBST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M
BST Dividend Payout.BST Dividend Payout, showing the Payout Ratio.BST Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BST Fundamentals: All Metrics, Ratios and Statistics

BLACKROCK SCIENCE & TECH TR

NYSE:BST (3/6/2026, 8:04:00 PM)

39.13

-0.67 (-1.68%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-05
Earnings (Next)N/A
Inst Owners19.5%
Inst Owner Change3.91%
Ins Owners0%
Ins Owner Change47.4%
Market Cap1.36B
Revenue(TTM)5.22M
Net Income(TTM)166.00M
Analysts0
Price TargetN/A
Short Float %0.11%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield 9.93%
Yearly Dividend2.96
Dividend Growth(5Y)-1.74%
DP62.65%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.26
Fwd PE N/A
P/S 260.27
P/FCF 13.06
P/OCF 13.06
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)4.74
EY12.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3
FCFY7.65%
OCF(TTM)3
OCFY7.65%
SpS0.15
BVpS40.67
TBVpS40.67
PEG (NY)N/A
PEG (5Y)N/A
Graham Number65.86
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 11.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3180.08%
GM N/A
FCFM 1992.34%
ROA(3y)-8.09%
ROA(5y)4.63%
ROE(3y)-8.04%
ROE(5y)4.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y17.43%
PM growth 5Y-3.35%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 62.65%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 31.35
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.2%
EPS 3Y22.37%
EPS 5Y-3.82%
EPS Q2Q%-54.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.96%
Revenue growth 3Y7.3%
Revenue growth 5Y8.06%
Sales Q2Q%58.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y316%
FCF growth 3YN/A
FCF growth 5Y6.67%
OCF growth 1Y316%
OCF growth 3YN/A
OCF growth 5Y6.67%

BLACKROCK SCIENCE & TECH TR / BST FAQ

What is the ChartMill fundamental rating of BLACKROCK SCIENCE & TECH TR (BST) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BST.


What is the valuation status of BLACKROCK SCIENCE & TECH TR (BST) stock?

ChartMill assigns a valuation rating of 1 / 10 to BLACKROCK SCIENCE & TECH TR (BST). This can be considered as Overvalued.


Can you provide the profitability details for BLACKROCK SCIENCE & TECH TR?

BLACKROCK SCIENCE & TECH TR (BST) has a profitability rating of 1 / 10.


What is the valuation of BLACKROCK SCIENCE & TECH TR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BLACKROCK SCIENCE & TECH TR (BST) is 8.26 and the Price/Book (PB) ratio is 0.96.


How financially healthy is BLACKROCK SCIENCE & TECH TR?

The financial health rating of BLACKROCK SCIENCE & TECH TR (BST) is 5 / 10.